How Safe Are the Covid Vaccines vs Ivermectin and Remdesivir?

Executive Summary

  • What is curious is health authorities promote vaccines and Remdesivir as safe and Ivermectin as not safe.
  • We cover this comparative safety.

Introduction

This article shows the adverse reaction comparisons between the covid vaccines, Remdesivir and Ivermectin, as tabulated by the WHO.

Our References for This Article

If you want to see our references for this article and related Brightwork articles, visit this link.

The WHO’s VigiAccess Adverse Reaction System

The following information is found at the website VigiAccess.gov, which is a website maintained by the WHO.

The Adverse Reactions for The Covid Vaccines

I found a source that stated that 7.8 billion doses of vaccines have been given. 

The Adverse Reactions for The Remdesivir

I could not find a source for the number of Remdesivir doses given, but it is very small compared to covid vaccines and Ivermectin. The FDA only approved Remdesivir in October 2020. I guessed 2.5 million doses based on reading about the number of dosages purchased and manufactured per month.

  • The drug was approved in October 2020
  • I found an article that stated as of June 2020 that, the US had purchased “500,000 doses, which is all of Gilead’s production for July and 90% of August and September,” which means that the production at that time was roughly 250,000 per month — although this is pre-approval.
  • I found an article in August of 2021 that the production that by June of 2021, the manufacturing had increased by 3x to 12.2 million. If we take June to November of 2021 at 12.2, that is 6 x 12.2 = 73.3 million.
  • I found an article in April of 2021 that the 3.8 million doses per month were being manufactured. However, the level before April was much lower. If we take 3.8 million from October 2020 to April of 2021, that is 7 * 3.8 = 26.6 million.
  • 26.6 million + 73.3 million = 102.9 million

At the 14:00 mark, this excellent video explains that Fauci rigged an NIH study on Remdesivir by changing the endpoint from mortality to time to recovery to match with the reduced benefits of Remdesivir. This was done to enrich Gilead. Fauci has a pattern of announcing things while being interviewed before the study being published. 

Remdesivir is a bust as a drug. Highly expensive, ineffective, and with high adverse reactions.

The Adverse Reactions for Ivermectin

I found a source that stated that 3.7 billion doses of vaccines had been given. 

Mathematical Comparison #1: Adverse Reactions Reported  Per Dose

  • Covid Vaccines Problems per Dose = 7.8 Billion / 2.7 Million = 28,888
  • Remdesivir Problems per Dose = 102.9 Million / 7859 = 13,192
  • Ivermectin Problems per Dose = 3.7 Billion / 5812 = 636,613

What should also be noted is that while Ivermectin is roughly $1 per dose, Remdesivir is $3120 per dose.

And Ivermectin has proven to be more than 3x more effective than Remdesivir while having far more studies. You can see this in the article How Effective is Ivermectin Versus the Pfizer and Moderna Corona Vaccines?

Technical Reason for Ivermectin’s High Degree of Safety

Ivermectin is approved for use as an antiparasitic, and Ivermectin does many things and is not just antiparasitic. However, the following explains why Ivermectin is effective against insects while not toxic to mammals.

Ivermectin and its related drugs act by interfering with the nerve and muscle functions of helminths and insects.[81] The drug binds to glutamate-gated chloride channels common to invertebrate nerve and muscle cells.[82] The binding pushes the channels open, which increases the flow of chloride ions and hyper-polarizes the cell membranes,[81] paralyzing and killing the invertebrate.[82] Ivermectin is safe for mammals (at the normal therapeutic doses used to cure parasite infections) because mammalian glutamate-gated chloride channels only occur in the brain and spinal cord: the causative avermectins usually do not cross the blood–brain barrier, and are unlikely to bind to other mammalian ligand-gated channels.[82] – Wikipedia

Another issue regarding Ivermectin’s excellent safety profile is the following.

The discovery of ivermectin has been described as a combination of “chance and choice.” Merck was looking for a broad-spectrum anthelmintic, which ivermectin is indeed; however, Campbell noted that they “…also found a broad-spectrum agent for the control of ectoparasitic insects and mites.”[88]

Merck began marketing ivermectin as a veterinary antiparasitic in 1981.[6] By 1986, ivermectin was registered for use in 46 countries and was administered massively to cattle, sheep and other animals.[89] By the late 1980s, ivermectin was the bestselling veterinary medicine in the world.[6] Following its blockbuster success as a veterinary antiparasitic, another Merck scientist, Mohamed Aziz, collaborated with the World Health Organization to test the safety and efficacy of ivermectin against onchocerciasis in humans.[9] They found it to be highly safe and effective,[90] triggering Merck to register ivermectin for human use as “Mectizan” in France in 1987.[9] A year later, Merck CEO Roy Vagelos agreed that Merck would donate all ivermectin needed to eradicate river blindness.[9] In 1998, that donation would be expanded to include ivermectin used to treat lymphatic filariasis.[9]

Ivermectin earned the title of “wonder drug” for the treatment of nematodes and arthropod parasites.[91] Ivermectin has been used safely by hundreds of millions of people to treat river blindness and lymphatic filariasis.[6] – Wikipedia

Analysis of Remdesivir Studies

The following presentation slides are from the document Whose Interests Do Public Health Officials Represent?

This slide analyzes a study that indicates that Remdesivir is a weak antiviral. 

And this does the same. 

The China study also found that Remdesivir was not an antiviral.

The studies showed that Remdesivir was so dangerous it was removed from use by the FDA’s Data and Safety Monitoring Board. 

This slide highlights that Remdesivir causes skin and liver abnormalities. Remdesivir is utterly toxic to the liver, and it has been widely prescribed and must have ruined the organs of many patients. This brings up how these side effects were covered up at hospitals. And the answer is that they were all attributed to covid. 

 

Another patient has organ failure, such as renal or kidney failure. Observe this chilling quote.

On Feburary 5, because of the disease severity and the persistence of viral detection, Remdesivir was re-initiated. Mulitiple organ failure persisted without any other co-infections identified. He died on Feburary 14.

Amazing.

Another organ failure, this time the liver. This patient’s body repaired itself — after Remdesivir was discontinued.

And another patient with kidney damage and multiple organ failure. And another dead patient.

Four of the five patients experienced significant side effects. How can such a drug not be disallowed for common usage? The quote states that kidney failure could have been related to SARS-CoV-2, but that is not what covid does.

The many conflicts with the maker of Remdesivir, Gilead Sciences. 

This first slide note observes that the seven patients with “no treatment data” would be a very convenient place to hide solid adverse reactions. Remdesivir constantly has strong negative reactions — so Gilead would have pressured the study’s conductors to “lose that data.” Only (8 + 53) = 61 study subjects were in the study, and losing 8 / 61 = 13% of the data is impressive. Why was this study even submitted for publication? Why did the New England Journal of Medicine publish it? This, along with other observations I have taken from studies published in NEJM, indicates that NEJM has no standards. 

Also, the New England Journal of Medicine had no problem accepting a study funded by Gilead Sciences when it knew that Gilead would rig the survey to produce a false outcome. This is why the slide comments that the statement of 36 of 53 patients seeing clinical improvement needed to be independently reviewed.

This note observes that due to Remdesivir’s well-established pattern of damaging organs, a shorter treatment keeps the outcomes from being seen in the organs. Of course, Gilead needed an excuse, so they came up with the idea that more patients could be treated. So apparently, Gilead did not have much of its product for the study, which is difficult to believe. They are also lying about the results of Remdesvir during the Ebola studies. 

This slide points out that Gilead Sciences most likely ghostwrote this entire study and then shopped around (a common tactic of pharmaceutical companies) to different prestigious scientists to place their names on in return for compensation. 

Addressing the Damage

One of the best ways to address the damage caused by the covid vaccines is with Ivermectin. This is the reason I began taking Ivermectin -- before investigating all the other health benefits of the drug. Now, I take Ivermectin for many reasons.

  • We have Ivermectin dosage calculators based on research studies and for all the different uses of Ivermectin.
  • We are the only web source offering an Ivermectin dosage calculator in addition to different dosage estimates for different cancer types.
  • All of our calculators are easy to use (see our dosage calculator listing). Each person enters their personalized information into the calculator and receives our recommended extensively researched dosage estimate automatically and immediately calculated.
  • We also cover the broader problems with dosage calculation in medicine at the article The Problem With Dosage Calculation in Medicine, as this is an issue much larger than for one drug. 

About Our Ivermecting Testing Program and Recommended Ivermectin Source of Supply

  • We performed pharmaceutical testing on Ivermectin to find a lower-cost version that also matched Merck's original Ivermectin in bioequivalence.
  • You can read about the details of our Ivermectin testing in this article, Our Ivermectin Bioequivalence Testing.
  • We got Summit Products to carry this version of Ivermectin, which passed our bioequivalence testing.